20
Aurobindo Pharma Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Irbesartan, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2009-283 - Rev 06
This Chemical Type CEP, issued on January 23, 2020, remains in force until September 29, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2465 associated with this CEP further emphasizes